Argus Investors Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Buy
3,120
+103
+3% +$24K 0.61% 42
2026
Q1
$737K Buy
3,017
+980
+48% +$228K 0.66% 41
2025
Q4
$422K Hold
2,037
0.34% 69
2025
Q3
$378K Sell
2,037
-2,722
-57% -$466K 0.3% 73
2025
Q2
$727K Sell
4,759
-273
-5% -$42K 0.52% 52
2025
Q1
$835K Sell
5,032
-1,714
-25% -$268K 0.64% 44
2024
Q4
$976K Sell
6,746
-55
-0.8% -$8.52K 0.65% 46
2024
Q3
$1.1M Sell
6,801
-2,094
-24% -$334K 0.72% 48
2024
Q2
$1.3M Sell
8,895
-1,069
-11% -$159K 0.8% 44
2024
Q1
$1.58M Buy
9,964
+572
+6% +$91K 0.97% 38
2023
Q4
$1.47M Buy
9,392
+84
+0.9% +$12.9K 0.95% 50
2023
Q3
$1.45M Sell
9,308
-330
-3% -$54.5K 1.04% 40
2023
Q2
$1.6M Buy
9,638
+430
+5% +$69.4K 1.11% 37
2023
Q1
$1.43M Buy
9,208
+472
+5% +$76.2K 1.08% 43
2022
Q4
$1.54M Hold
8,736
1.24% 34
2022
Q3
$1.43M Sell
8,736
-2,200
-20% -$372K 1.27% 29
2022
Q2
$1.94M Buy
10,936
+61
+0.6% +$10.9K 1.43% 24
2022
Q1
$1.93M Sell
10,875
-1,001
-8% -$170K 1.23% 37
2021
Q4
$2.03M Sell
11,876
-5,737
-33% -$939K 1.22% 37
2021
Q3
$2.84M Sell
17,613
-8,136
-32% -$1.39M 1.86% 13
2021
Q2
$4.24M Sell
25,749
-2,544
-9% -$421K 1.73% 19
2021
Q1
$4.65M Buy
28,293
+4,178
+17% +$676K 1.88% 18
2020
Q4
$3.79M Sell
24,115
-5,025
-17% -$742K 1.66% 34
2020
Q3
$4.34M Buy
29,140
+1,800
+7% +$266K 1.79% 28
2020
Q2
$3.85M Sell
27,340
-1,100
-4% -$160K 1.87% 25
2020
Q1
$3.73M Sell
28,440
-700
-2% -$99.3K 2.22% 14
2019
Q4
$4.25M Sell
29,140
-225
-0.8% -$30.5K 1.94% 26
2019
Q3
$3.8M Hold
29,365
1.84% 32
2019
Q2
$4.09M Sell
29,365
-500
-2% -$69.2K 1.97% 27
2019
Q1
$4.17M Hold
29,865
2% 23
2018
Q4
$3.85M Sell
29,865
-2,500
-8% -$349K 2.01% 28
2018
Q3
$4.47M Sell
32,365
-2,759
-8% -$367K 1.92% 25
2018
Q2
$4.26M Buy
35,124
+3,951
+13% +$493K 1.95% 22
2018
Q1
$4.05M Buy
31,173
+803
+3% +$109K 2.01% 24
2017
Q4
$4.24M Sell
30,370
-803
-3% -$112K 1.96% 32
2017
Q3
$4.05M Sell
31,173
-3,100
-9% -$411K 2.01% 24
2017
Q2
$4.53M Sell
34,273
-1,327
-4% -$169K 2.04% 15
2017
Q1
$4.43M Sell
35,600
-4,550
-11% -$544K 2.07% 3
2016
Q4
$4.63M Sell
40,150
-600
-1% -$69.3K 1.93% 26
2016
Q3
$4.81M Sell
40,750
-1,550
-4% -$188K 2.02% 13
2016
Q2
$5.13M Sell
42,300
-2,500
-6% -$284K 2.17% 3
2016
Q1
$4.85M Sell
44,800
-4,050
-8% -$419K 2.02% 17
2015
Q4
$5.02M Sell
48,850
-1,655
-3% -$166K 2.13% 13
2015
Q3
$4.71M Hold
50,505
2.05% 19
2015
Q2
$4.92M Sell
50,505
-175
-0.3% -$17.5K 2.03% 28
2015
Q1
$5.1M Buy
50,680
+2,900
+6% +$295K 2.05% 24
2014
Q4
$5M Sell
47,780
-550
-1% -$58K 2.05% 24
2014
Q3
$5.15M Sell
48,330
-210
-0.4% -$21.8K 2.16% 10
2014
Q2
$5.08M Sell
48,540
-5,350
-10% -$541K 2.12% 11
2014
Q1
$5.29M Sell
53,890
-250
-0.5% -$23.2K 2.17% 8
2013
Q4
$4.96M Hold
54,140
2.02% 20
2013
Q3
$4.69M Sell
54,140
-4,090
-7% -$367K 2.12% 11
2013
Q2
$5M Buy
+58,230
New +$4.94M 2.18% 5

Other funds holding JNJ

Argus Investors Counsel's JNJ Position: Q2 2026 in Review

Argus Investors Counsel increased its Johnson & Johnson (JNJ) stake by 3.4% in Q2 2026, buying an estimated $24K and bringing the position to 3,120 shares worth $792K. The position accounts for 0.61% of the portfolio, ranked #42.

Argus Investors Counsel first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.29M in Q1 2014. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Argus Investors Counsel held 3,120 shares of Johnson & Johnson worth $792K as of Q2 2026.
  • Argus Investors Counsel bought 103 Johnson & Johnson shares in Q2 2026, an estimated $24K.
  • Johnson & Johnson made up 0.61% of Argus Investors Counsel's portfolio in Q2 2026, its #42 holding.
  • Argus Investors Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Argus Investors Counsel's Johnson & Johnson position peaked at $5.29M in Q1 2014.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Argus Investors Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.